Towards an MMP-2-activated molecular agent for cancer imaging

Dalton Trans. 2018 Jan 30;47(5):1530-1534. doi: 10.1039/c7dt03108d.

Abstract

Matrix metalloproteinases (MMPs) have been identified as biomarkers for cancer, offering prognostic potential; however, non-invasive detection protocols are currently lacking. Herein, we describe the synthesis of a DOTA-containing peptide sequence that can be radiolabelled easily with 68Gallium or can be incorporated with gadolinium for possible MRI applications with clear selectivity for MMP-2 over other members of the MMP family, giving MMP-2 selective cleavage of the labelled peptides.

MeSH terms

  • Amino Acid Sequence
  • Enzyme Activation / drug effects
  • Gadolinium / chemistry
  • Gallium Radioisotopes
  • Heterocyclic Compounds, 1-Ring / chemistry
  • Magnetic Resonance Imaging / methods*
  • Matrix Metalloproteinase 2 / metabolism*
  • Neoplasms / diagnostic imaging*
  • Neoplasms / metabolism
  • Organometallic Compounds / chemistry
  • Organometallic Compounds / pharmacology*
  • Peptides / chemistry

Substances

  • Gallium Radioisotopes
  • Heterocyclic Compounds, 1-Ring
  • Organometallic Compounds
  • Peptides
  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Gallium-68
  • Gadolinium
  • Matrix Metalloproteinase 2